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 6.5.1  INTRODUCTION 
 Controlled - release technology for drug delivery applications is designed to target 
the drug to particular places or cells in the body, to overcome certain tissue and 
cellular barriers, and to control the duration and level of the drug in the body within 
a spefi cied therapeutic window. This usually implies achieving a prolonged, zero -
 order release rate over the desired duration of drug delivery. Controlled - release 
dosage forms provide sustained drug release and require less frequent drug loading 
than conventional forms. Thus, the toxic side effects of the drug are minimized and 
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patient ’ s convenience and compliance are improved. Controlled - release systems are 
usually classifi ed into four categories based on the rate - limiting step of the release 
process  [1] : (1) diffusion - controlled systems, (2) chemically controlled systems, 
(3) swelling - controlled systems, and (4) magnetically controlled systems. Diffusion -
 controlled systems are formulated in two main geometries: reservoirs and matrices. 
In matrix systems, the drug is generally uniformly distributed or dissolved through-
out a polymer. The release kinetics from these types of systems depend on the 
quantity and the diffusivity of drug in the matrix and the geometry of the system. 
The release rates from matrix systems usually decrease with time due to an increase 
in the pathlength for diffusion of drug and, thus, their release characteristics are not 
generally zero order. In the case of chemically controlled systems, the drug is either 
distributed through a biodegradable polymer or chemically bound to a polymer 
backbone chain. The drug release from the biodegradable polymer is controlled by 
degradation of the polymer through penetration of water or a chemical reaction  [1] . 
The drug attached to the polymer is released by hydrolytic or enzymatic cleavage. 
In swelling - controlled systems, the drug is dissolved or distributed in a glassy polymer 
matrix. As water penetrates the dry matrix, the polymer swells and its glass transi-
tion temperature decreases below the temperature in the matrix. As a result, the 
glassy – rubbery transition occurs and it allows the release of the drug. The release 
rate of the drug out of these systems is mainly controlled by the rate and degree of 
swelling. Alternatively, the drug release can also be controlled magnetically by dis-
persing the drug and small magnetic beads within a polymer matrix and exposing 
them to an oscillating external magnetic fi eld. (The drug is released as the matrix is 
exposed to an oscillating external magnetic fi eld.) 
 Reservoir systems consist of a drug - containing core surrounded by a polymer 
membrane. The release rate of drug is controlled by its diffusion through the mem-
brane  [1, 2] . In addition to diffusional release, osmotic pumping mechanisms 
contribute to the total drug release rate if either the drug is highly soluble or an 
osmotic agent is added to the active core  [1 – 4] . Reservoir systems are prepared in 
different geometries, such as coated tablets, beads, particles, membrane - based 
pouches, and microcapsules. The main advantage of these systems is their ability 
to maintain zero - order release rates  [1, 2] . This is usually achieved by loading the 
powdered form of drug at a level far above the solubility of drug. Then, the con-
centration of drug at the internal wall of the reservoir becomes its saturation 
concentration and zero - order release occurs until the drug is completely dissolved. 
In addition, drug loading can be higher for these systems compared to other con-
trolled - release systems; thus, the cost of formulation is minimized and the drug is 
released at a higher rate for a longer period of time. The major disadvantage of 
the reservoir system is rupture of the rate - controlling membrane if it is subject to 
dose dumping. 
 Numerous studies exist in the literature on the drug release from tablet coatings. 
In the majority of these studies, diffusional drug release takes place from the coat-
ings  [5 – 17] . Various factors such as the type  [8, 10, 15] , and concentration of the 
coating material  [7, 8, 11] , the type and amount of the plasticizer in the coating 
solution  [10, 12, 15] , the thickness of the coating  [5] , the composition of the tablet 
core  [6, 14] , the particle size of the coating material  [10, 18] , and the weight gain of 
the coating  [7, 8, 11, 13, 16] were considered during the formulation of tablet coat-
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ings, and their effects on the drug release rates were investigated. The use of osmotic 
tablet coating systems are also described in the literature  [3, 4, 17, 19 – 23] . Osmotic 
systems utilize osmotic pressure difference as a driving force, and in the simplest 
design they consist of an osmotic core containing drug with and without osmotic 
agents. Different studies have shown that the release rate of drugs from oral osmotic 
pump tablet coating systems is governed by various formulation variables such as 
solubility and osmotic pressure of core components  [3, 4, 19 – 23] , number  [17] and 
size of the delivery orifi ce  [3, 4, 20, 21, 23] , drug loading  [3, 4, 17] thickness of the 
coating  [3, 4, 19, 21, 23] , composition of the coating solution  [3, 4, 17, 20, 21, 23] , and 
weight of the coating  [17, 20, 22] . The coatings prepared in most of these studies 
have dense structures with or without a hole drilled through the coating through 
which the drug is delivered. In some cases, drug delivery ports are formed by adding 
leachable materials to the coating  [24, 25] . The main problem with these systems, in 
the absence of a hole, is an excessively prolonged drug release due to the low per-
meability of the coating. To increase permeability of the coatings, plasticizers and 
water - soluble additives were incorporated in the coating solution, and multilayer 
composite coatings  [14, 15, 24, 26, 27] or multiple - compartment osmotic tablets were 
prepared  [17, 22, 28, 29] . The permeability of the tablet coating systems were further 
improved by changing the structure of the coatings from dense to porous asym-
metric ones  [30 – 42] . Asymmetric membrane tablet coatings are characterized by 
a relatively thin, dense skin layer supported on a highly permeable, thicker, and 
porous sublayer. The permeabilities and the release rates of the drugs through the 
asymmetric - membrane capsule/tablet coatings were determined to be higher com-
pared to conventional dense tablet coatings  [30, 33, 34, 39] . The composition of the 
coating solution was found to have a signifi cant effect on the structure of these type 
of coatings and thus on the release rate of the drug  [30, 33, 35, 36, 39, 40 – 42] . In 
addition, it was reported that the drying condition had a signifi cant impact on the 
structure of the asymmetric - membrane tablet coating and the release rate of the 
drug  [41] . A review of the literature studies clearly indicates that asymmetric - type 
tablet coating is a new solution for developing controlled drug delivery systems, 
since the structure of these types of coatings can be varied easily by changing the 
preparation conditions without altering the coating material or signifi cantly varying 
the coating thickness. 
 This work contains six sections in addition to the introduction. Section  6.5.2 –  6.5.5 
present a brief review of manufacturing methods for the application of coating 
materials on tablets, characterization methods used to evaluate the uniformity and 
defects of the tablet coatings, the techniques commonly used for manufacturing 
asymmetric - type membranes, and modeling approaches employed for optimization 
of the tablet coating formulations. The aim of the last two sections is to demonstrate 
the advantages of asymmetric membrane tablet coatings with respect to their drug 
release properties and the factors that affect the morphology of these types of tablet 
coatings. To achieve this goal, the in vitro release of a model compound, theophyl-
line, from asymmetric membrane tablet coatings is determined and the morphology 
of the coatings is examined. In addition, the dynamics of the phase inversion is 
quantifi ed in terms of ternary - phase diagrams coupled with composition paths 
determined from a mathematical model developed previously by our group  [43] . 
To draw meaningful and objective conclusions from experimental data and derive 
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an empirical expression for the release rate of drug, compositions of the coating 
solution are chosen using a statistical experimental design. 
 6.5.2  TABLET COATING METHODS 
 Four basic methods are commonly used for the application of coating materials on 
drug tablets: (1) pan coating, (2) fl uidized - bed coating, (3) compression (press) 
coating, and (4) melt/dry coating. 
 Pan Coating  The pan coating process is the oldest form of pharmaceutical coating 
for manufacturing small, coated particles or tablets. In this process, the particles 
are tumbled in a pan which is rotated at an angle of usually 45  ° to the horizontal 
surface at a speed between 20 and 50  rpm  [44] . Coating fl uid is sprayed onto the 
particles from a above by means of an air jet. The hot air blown through the coater 
evaporates the fl uid and dries the fi lm coating. Pan coating is generally preferred 
to coat large tablets since they are exposed to mechanical damage in other coating 
operations. The uniformity of the coating applied to the tablets and defects on the 
coating are important issues from a practical point of view. Operating conditions 
such as drum speed, drum solids loading, the presence/absence of baffl es, air veloc-
ity, and temperature infl uence the movement of tablets within the moving bed, the 
circulation and surface exposure times spent by a tablet in the bulk of the moving 
bed and on the surface of the bed, respectively, and the rate of drying, which all in 
turn determine the uniformity of the coating in a pan coating process  [45] . Different 
experimental tools such as light emission from a single luminous tablet, photo-
graphic and manual counting, positron emission particle tracking, magnetic reso-
nance imaging, and near real - time video imaging techniques  [45 – 51] were used to 
study the motion of tablets in the drum. Simulation of particle movement using 
discrete - element modeling has also been used to study the movement of tablets 
 [52 – 55] . In addition, statistical experimental design was utilized to identify the criti-
cal processing variables that affect coating uniformity and loading of active agent 
coated on tablets  [56] . Inlet airfl ow, pan speed, inlet air temperature, coating time, 
atomization pressure, and fan pressure were investigated as the process variables. 
Among these variables, atomization pressure, pan speed, and duration of coating 
were found to be critical process variables with respect to uniformity of the 
coating. 
 Fluidized - Bed Coating  The basic principle of fl uidized - bed coating is to suspend 
tablets in a moving hot - air stream in the upward direction during the coating 
process. The coating material is sprayed through a nozzle from the top, the side, or 
the bottom into the fl uidized bed. The solvent in the solution is removed from 
the coating by the hot - air stream, which also carries the coated tablets/particles. 
Fluidized - bed coating provides better coating uniformity due to good solid – fl uid 
mixing and minimizes formation of agglomerates. There are various types of 
fl uidized - bed coating equipment, the most commonly used confi guration being the 
Wurster column coater  [44] , in which a draft tube insert is placed coaxially in the 
bed to aid the circulation of particles. This column is not suitable for coating of large 
particles and tablets due to high erosion of solids associated with the higher velocity 
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needed to circulate them  [57] . Typical operating variables that affect the perfor-
mance of the fl uid bed coating in a Wurster column are airfl ow rate, air and bed 
temperature, spray rate, gap height between the draft tube and the air distributor 
plate, atomizing air pressure, humidity, and solids charge. The product coating uni-
formity in the Wurster column coating process is primarily determined by the varia-
tion in coating per pass and the circulation time distribution. Radioactive particle 
tracing, magnetic particle tracing, and controlled single - or multiple - pass coating 
evaluation techniques were commonly used for detecting particle circulation time 
and distribution  [57, 58] . In addition, several models have been developed to predict 
the amount of material coated on the particles  [59 – 65] . 
 Compaction Coating  In this process, the coating is compressed around a pre-
formed core by using a special tablet press. Compaction coating is especially useful 
when the drug itself is unstable in the solution and precipitates from the solution 
in a less stable morphology. On the other hand, the large amount of coating material 
required limits the applicability of this technology. Another disadvantage of the 
process is poor adhesion at the coating – core interface which causes physical instabil-
ity (i.e., friability)  [66] . The Press coating process is not useful for coating relatively 
hard cores which provide essentially no compressibility. 
 Melt/Dry Coating  Film coating processes require water or organic solvent(s). The 
use of organic solvents causes environmental pollution and excessive cost of recov-
ery while a long time is required to remove the aqueous solvent. Both hot - melt and 
dry coating techniques eliminate the use of solvents; as a result the processing times 
become much shorter and the cost of the process is reduced. Melt coating is possible 
for coating materials that have a low melting temperature and acceptable thermo-
stability. The principal stages in the fi lm formation during dry coating are softening, 
melting, and curing  [67 – 70] . The process requires larger amount of plasticizer to 
partially soften and dissolve the polymer. 
 6.5.3  CHARACTERIZATION OF TABLET COATINGS 
 Tablet coatings are applied to improve tablet swallowability, mask unpleasant 
tastes and odors, protect the tablet core against water and oxygen, which can 
degrade the drug in the core, and control the release rate of the drug. The rate of 
dissolution and bioavailability of a drug are primarily infl uenced by the quantity 
and quality of the coating applied on the tablet. Thus, the characterization of the 
coatings becomes essential in terms of the uniformity and integrity of the coating. 
A number of instrumental methods ranging from liquid chromatography  [71] to 
various noninvasive spectroscopic probes have been introduced and evaluated as 
a means of monitoring the coating process. Among these methods, laser - induced 
breakdown spectroscopy (LIBS) has been used as a rapid technique for assessing 
the uniformity of the coating thickness  [72] ; however, the destructive nature of the 
method has also been reported  [73] . Near - infrared spectroscopy has been employed 
for determining the amount of coating applied  [74 – 76] . The main disadvantage of 
this method has been identifi ed as imprecision in the calibration and validation 
models due to uneven distribution of coating from tablet to tablet  [77] . Microscopy 
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techniques provide direct and accurate measurement of the coating thickness but 
require laborious sample preparation and are therefore impractical for real - time 
process monitoring. Recently, Raman spectroscopy combined with multivariate 
data analysis has been reported as a feasible noninvasive technique to quantify 
tablet coating thickness and uniformity in the presence of a fl uorescent ingredient 
in the coating formulation  [77, 78] . Confocal laser scanning microscopy has been 
introduced as a novel technique for imaging the fi lm – core interface and surface 
defects of fi lm - coated tablets  [79] . Surface roughness was also determined as an 
important factor in characterizing the tablet coatings using different imaging and 
roughness analytical techniques, including optical microscopy, scanning electron 
microscopy (SEM), laser profi lometry, and atomic force microscopy (AFM) 
 [80 – 84] . 
 6.5.4  PREPARATION OF ASYMMETRIC MEMBRANES 
 Asymmetric membranes are usually produced by phase inversion techniques. In 
these techniques, an initially homogeneous polymer solution becomes thermody-
namically unstable due to different external effects and the phase separates into 
polymer - lean and polymer - rich phases. The polymer - rich phase forms the matrix of 
the membrane, while the polymer - lean phase, rich in solvents and nonsolvents, fi lls 
the pores. Four main techniques exist to induce phase inversion and thus to prepare 
asymmetric porous membranes  [85] : (a) thermally induced phase separation (TIPS), 
(b) immersion precipitation (wet casting), (c) vapor - induced phase separation 
(VIPS), and (d) dry (air) casting. 
 Thermally Induced Phase Separation  In the TIPS process, an initially homoge-
neous solution consisting of a polymer and solvent(s) phase separates due to a 
decrease in the solvent quality when the temperature of the casting solution is 
decreased. After demixing is induced, the solvent is removed by extraction, evapora-
tion, or freeze drying. 
 Immersion Precipitation (Wet Casting)  A homogeneous polymer solution con-
sisting of a polymer and solvent(s) is cast on a support and is immersed in a non-
solvent bath. During the immersion, casting solvent diffuses into the nonsolvent 
bath and, countercurrently, nonsolvent in the bath penetrates into the solution. The 
nonsolvent has a limited solubility in the polymer, and when it reaches its critical 
concentration in the solution, precipitation takes place. Then, the solvent and non-
solvent in the solution are extracted and fi lm is annealed. 
 Vapor - Induced Phase Separation  During the VIPS process, phase separation 
is induced by penetration of nonsolvent vapor, into the homogeneous polymer 
solution consisting of polymer and solvent(s). Mass transfer is usually much 
slower than that in the wet casting process; thus, the VIPS process has been 
used to obtain membranes with symmetric, cellular, and interconnected pores 
 [86, 87] . 
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 Dry (Air) Casting  In this process, the polymer is dissolved in a mixture of a vola-
tile solvent and a less volatile nonsolvent is cast on a support and exposed to an air 
stream. During drying of the solution, fast solvent evaporation leads to a decrease 
in solubility of the polymer, then phase separation takes place. 
 6.5.5  METHODS FOR OPTIMIZATION OF TABLET 
COATING FORMULATIONS 
 Tablet coating formulation is composed of various formulation factors and process 
parameters. The formulation is usually divided into modeling and optimization 
phases. The modeling phase consists of preparing series of experimental formula-
tions by varying the ingredients and process conditions systematically and measur-
ing their properties. A detailed review of the literature indicates that the response 
surface method (RSM) has been widely used for modeling and choosing acceptable 
tablet coating and other pharmaceutical formulations. The RSM includes statistical 
experimental designs, multiple regression analysis, and optimization algorithms to 
search the best formulation for a given set of constraints. Full factorial, orthogonal, 
Box – Behnken, central composite, pseudorandom, and Plackett – Burman designs 
were used to investigate the effects of tablet core formulation, coating thickness, 
and process parameters such as mixing time and speed in the pan coating process, 
inlet airfl ow, pan speed, inlet air temperature, coating time, atomization pressure, 
and fan pressure in the fl uidized - bed coating process  [88 – 93] . Artifi cal neural net-
works (ANNs) have also been investigated as an alternative method for modeling 
the pharmaceutical formulations  [94 – 106] . In the RSM, the pharmaceutical responses 
are predicted based on the second - order polynomial equation, which is usually 
limited to low levels. When a nonlinear relationship between formulation factors 
and response variables is observed, the ANN approach was shown to give better 
estimations of optimal formulations  [106] . 
 6.5.6  APPLICATIONS 
 Previous sections have reviewed numerous studies in the literature investigating the 
release mechanisms from the tablet coating systems, their advantages/disadvantages 
as a control release system, and the methods used to characterize and optimize their 
formulation. In the following sections, the in vitro performance characteristics of 
the asymmetric membrane tablet coatings will be illustrated using release studies 
of a model compound theophylline. For this purpose, fi rst the method used for pre-
paring asymmetric membrane tablet coatings will be explained, then the results of 
the dissolution studies will be discussed. 
 6.5.6.1  Materials and Methods 
 Preparation and Characterization of Tablet Coatings  Tablet cores were pre-
pared by compressing the drug without any excipient using a hydraulic press oper-
ated at 110  MPa. A stainless steel die with a diameter of 1.2  cm was used to produce 
400 - mg drug tablet cores. Asymmetric - membrane tablet coatings were applied 
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using a dip coating process (Dip Coater Nima, type D1L, serial no. 327). The tablets 
were dip coated in polymer solutions prepared by dissolving cellulose acetate 
(Aldrich) in a solution of acetone (Merck) and water. The rate of withdrawal of 
the tablets from the solution was adjusted to obtain similar fi nal coating thicknesses 
for each coating formulation. Immediately after coating, tablets were rotated for 
even distribution of the viscous membrane solution, transferred into an environ-
mental chamber (Angelantoni Industrie, Italy, Challenge series, model number 
CH250), and kept there for 2  h to allow for evaporation of both the solvent (acetone) 
and nonsolvent (water). The temperature and relative humidity of air in the envi-
ronmental chamber were adjusted to 25 ° C and 50%, respectively. Tablets were 
allowed to dry further for a minimum of 24  h at room temperature prior to dissolu-
tion experiments. Faster evaporation of acetone and resulting increase in the con-
centration of water in the coating leads to a decrease in solubility of the cellulose 
acetate (CA); then phase separation takes place. Consequently, asymmetric - mem-
brane structure forms on the tablet core. Morphology of the coatings was examined 
using a scanning electron microscope (Philips, XL - 30SFEG). Samples were 
coated with gold palladium using a magnetron sputter coating instrument. The 
thickness of the dense skin layer, the overall porosity, and the average pore size 
were determined from image analysis of micrographs showing cross sections of the 
membranes. 
 Dissolution Studies  The release rate of theophylline from the tablets was deter-
mined by the U.S. Pharmacopeia (USP) XXIII dissolution methodology using a 
dissolution tester (Caleva 10ST). According to this standard, 900  ml of dissolution 
medium was placed in the vessel and the temperature was maintained constant at 
37 ° C using a constant - temperature bath. Then, the tablets were immersed in the 
vessel and the solution was stirred at a speed of 50  rpm. To simulate the actual 
dissolution environment in the body, the pH of the dissolution medium was 
kept at 3 during the fi rst 3.5  h by adding 8.5 vol % phosphoric acid to 900  mL dis-
tilled water and then increased to 7.4 by adding 5.3  M NaOH to the dissolution 
medium and kept at this value until the end of the experiment. To determine the 
quantity of drug released from the tablets, samples were taken periodically and 
assayed by ultraviolet (UV) spectrophotometry (Shimadzu UV - 1601) at a wave-
length of 272  nm. Dissolution experiments were performed on three tablets and 
the release profi les were reported as the arithmetic average of the three experi-
mental runs. 
 Statistical Experimental Design  To determine the infl uence of the composition 
of the coating solution on the release rate of drug, experiments were statistically 
designed using a commercial software package called Design - Expert  [107] . The 
system studied in this chapter consists of three components with the following com-
positional restrictions:
  5 15 70 90 5 151 2 3≤ ≤ ≤ ≤ ≤ ≤ω ω ω   (1) 
 where  ω  i  is the weight percent of component  i and 1, 2, 3 represent CA, acetone, 
and water, respectively. Any composition outside these limits will probably fail to 
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produce a successful asymmetric - membrane coating. In mixture experiments, the 
factors are the compositions of the mixture components, and the sum of the fractions 
of all components is equal to 1. Therefore the factor levels are mutually dependent. 
Thus, factorial experimental designs are not suitable for response surface modeling 
of mixtures since such designs require that the experimental treatment combina-
tions be determined by independent adjustments of each component level. In addi-
tion, a standard response surface design cannot be used either due to the same 
constraints. Consequently using the constraint levels shown in Equation  (1) , a  D -
 optimal design was generated by the Design - Expert software package. The 14 exper-
imental formulations determined are shown in Table  1 . The lower and upper limits 
on the weight fraction of each component are required to (a) obtain appropriate 
viscosity of the solution and coat the tablets uniformly and (b) induce phase separa-
tion, thus forming a porous membrane structure. These constraints were established 
based on preliminary dissolution experiments, available literature data, and the 
simulation results reported by Altinkaya and Ozbas  [43] . 
 Of the 14 formulations listed in Table  1 , six experimental runs were required to 
fi t the quadratic mixture model, four additional distinct runs were used to check for 
the lack of fi t, and fi nally four runs were replicated to provide an estimate of pure 
error. Design - Expert used the vertices, the edge centers, the overall centroid, and 
one point located halfway between the overall centroid and one of the edge centers 
as candidate points. Additionally, four vertices of the design region were used as 
check points  [107] . 
 Determination of Phase Diagrams and Composition Paths  The dynamics of the 
membrane formation process is predicted by combining the kinetics and thermody-
 TABLE 1  Theophylline Release Rates from Asymmetric - Membrane Tablet Coatings, 
Results of Fitting Release Profi les to Zero - Order Kinetics, and Precipitation Times 
Determined from Model Predictions 
 Compositon (wt %) 
 Release Rate 
(mg/min)  R 2 
 Precipitation 
Time  a  (s) 
 Cellulose 
Acetate  Acetone  Water 
 15  80  5  0.036  0.9871  2671/2671 
 15  80  5  0.036  0.9864  2671/2671 
 5  90  5  0.45  0.9757  660/660 
 5  90  5  0.36  0.9864  660/660 
 15  70  15  0.036  0.9908  3374/3374 
 15  70  15  0.027  0.9925  3374/3374 
 5  80  15  0.36  0.9928  1000/1000 
 5  80  15  0.36  0.9876  1000/1000 
 5  85  10  0.27  0.9918  675/675 
 10  80  10  0.054  0.9958  1751/1751 
 15  75  10  0.054  0.9975  2314/2314 
 10  85  5  0.036  0.9887  2554/2554 
 12.5  77.5  10  0.036  0.9902  — 
 10  75  15  0.063  0.9889  1484/1484 
  a  The fi rst number corresponds to the precipitation time at the tablet – coating interface. 
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namics of the system simultaneously. An appropriate thermodynamic model is 
necessary to construct the ternary - phase diagram and to formulate the boundary 
conditions of the kinetic model. Phase separation is considered to occur when a 
mass transfer path touches the binodal curve. In this study, a robust algorithm devel-
oped previously by our group was used to construct the phase diagram  [43] . The 
algorithm utilizes Flory Huggins thermodynamic theory with constant interaction 
parameters. The composition paths were determined from the kinetic model equa-
tions which consist of coupled unsteady - state heat and mass transfer equations, fi lm 
shrinkage, and complex boundary conditions. The details of both the thermodynam-
ics and kinetic equations can be found in our previous study  [43] . We have assumed 
that the kinetic model derived for a plane geometry can be used to predict the 
membrane formation process on a tablet surface. This assumption is fairly reason-
able since the thickness of the coating is very small and, thus, the cylindrical geom-
etry can be approximated as the plane geometry. 
 6.5.6.2  Results and Discussion 
 Effect of Composition of Coating Solution  The effect of changing the composi-
tion of the casting solution is well documented for asymmetric membranes prepared 
for separation applications  [108 – 115] . However, there are relatively few quantitative 
studies illustrating the relationship between the composition of the casting solution 
and the drug release rate from the asymmetric - membrane coated tablets/capsules 
 [30, 33] . To investigate such a relationship, the in vitro release profi les of the model 
drug theophylline were measured for the 14 formulations listed in Table  1 and they 
are shown in the  Appendix in Figures  A1 – A10 . To fi nd out whether the drug release 
from the tablet coatings provides a zero - order release kinetics, each data set was 
fi tted to a linear equation. The quality of the fi tted model is determined by the coef-
fi cient of determination  R 2 and it is defi ned as
  
R y y
y
2
=
−σ σ
σ
ˆ   (2) 
where
  
σy i
i
n
n
Y Y= −
=
∑1 2
1
( )
  
(3)
 
  ˆ ( ˆ )σy i i
i
n
n
Y Y= −
=
∑1 2
1
  
(4)
 
denote the sample variance and the prediction error power, respectively. Addition-
ally,  n is the number of experimental data points,  Y i is the experimental observation, 
 Y  is the average of the experimental data points, and  Yˆi  denotes the predicted value 
by the fi tted model. The quantity  R 2 lies between 0 and 1, and if the value is 1, it 
can be said that the fi t of the model is perfect. High  R 2 values listed in Table  1 for 
each data set indicate that there is an excellent linear relationship between the 
concentration of the drug and the release time; thus, all tablet coatings prepared 
3
c27.indd   1110 11/6/2007   7:30:29 PM
APPLICATIONS  1111
can provide zero - order or near - zero - order drug release. The release rates for each 
coating formulation were estimated from the slope of the average release profi les 
and they are also listed in Table  1 . 
 The drastic change in the release rates with the composition of the coating solu-
tion is shown in Figure  1 . Within the experimental composition range covered, the 
highest release rate was observed in the case of the lowest CA (P: polymer) and the 
highest acetone (S: solvent) concentrations in the casting solution [polymer (P) –
 solvent (S) weight fraction ratio 5/90]. This is caused by the fi nal coating structure 
consisting of a very thin and dense top skin layer, and highly porous lower sublayer, 
as illustrated in Figure  2 . At the lowest level of polymer concentration (5%), the 
 FIGURE 1  Release rate of theophylline as function of cellulose acetate(P) – acetone(S) 
weight fraction ratios. 
 FIGURE 2  SEM of cross section of asymmetric - membrane made with 5% water and 
CA – acetone weight ratio of 5/90, magnifi cation 2500 × . 
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thicknesses of the dense skin layers of the coatings are very small and similar to 
each other; thus, the structure of the lower sublayer becomes an important factor 
in determining the release rate of the drug. The porosity of the coating structure in 
the case of 90% acetone is so high that an increase in water concentration from 5 
to 10% is not suffi cient to produce a more porous fi nal structure and, thus, the 
release rate of the drug decreases. A further increase of water concentration to 15% 
results in an opposite effect, which makes the release rate increase to a level of 
0.36  mg/min due to the dominant effect of water concentration in increasing the 
porosity of the lower sublayer. 
 An increment in the CA concentration from 5 to 10% resulted in signifi cantly 
lower release rates at all water concentrations because the structure of the coatings 
changed from porous to dense. Keeping the polymer concentration at 10% while 
changing the water concentration from 5 to 15% makes the release rates increase. 
This behavior is explained by the formation of more porous structures by adding 
more nonsolvent into the casting solution, which is in agreement with the observa-
tions of other groups  [30, 33] . 
 When the polymer concentration increases from 10 to 15%, no signifi cant 
changes in release rates were observed. As a matter of fact, in the cases of 5% 
and 10% water concentrations, the release rates did not change at all. This is due 
to the unusual transport characteristics of asymmetric membranes which are 
complex functions of the properties of the different regions of the membrane. In 
addition to the thickness of the dense skin layer and the porosity of the lower 
sublayer, structural factors such as tortuosity, pore size, shape, and connectivity 
of the pores also strongly affect the rate of transport through the coating. The 
SEM pictures taken at high magnifi cation which are shown in Figures  3 a and 3 b 
indicate that the tablet coating prepared with a P/S ratio of 10/85 has a uniform 
and narrow pore size distribution with regular elliptic pore shapes, while the 
other one (P/S: 15/80) has cylindrical pores with a wide pore size distribution, 
forming a connected pore network. As a result, even though the resistance of the 
dense skin layer of the coating made with P/S ratio of 15/80 is larger, its lower 
sublayer resistance is smaller due to the connected pore network. Consequently, 
the release rate of the theophylline becomes the same through both tablet coat-
ings. Comparison of the scanning electron micrographs in Figures  4 a and 4 b indi-
cates that the tablet coating made with the P/S ratio of 10/80 has a uniform pore 
size distribution, cylindrical pore shapes and high tortuosity while the tablet 
coating prepared with the P/S ratio of 15/75 has elliptic, irregular pore shapes 
and pores are isolated. Thus, the lower sublayer resistance of the coating made 
with the P/S ratio of 10/80 is larger due to the relatively higher tortuosity result-
ing in the same release rate with the coating prepared with the P/S ratio of 
15/75. 
 At the 15% polymer concentration level, the release rate increases with the 
change in water concentration from 5 to 10%, which is mainly caused by the 
increased porosity. However, a further 5% increment in the water concentration 
(to 15%) made the release rate decrease back to the same level as in the case of 
5% water concentration. Even though higher water concentration favors forming 
a more porous structure and a concomitant higher release rate, the acetone level 
which decreased below a critical value destroyed this mechanism. 4
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 Results of dissolution studies along with morphological observations clearly 
indicate that the drug release rate is strongly infl uenced by the morphology of 
the membrane. Thus, if one wishes to control the drug release characteristics of the 
delivery system, a quantitative understanding of the dynamics and morphology of 
the phase inversion process is required. The dynamics of the phase inversion process 
can be quantifi ed in terms of the ternary - phase diagram coupled with the heat and 
mass transfer model equations. We have obtained information about the structure 
of the tablet coating by plotting the composition paths on the ternary - phase diagram 
and the polymer concentration profi le at the moment of precipitation. As an illustra-
 FIGURE 3  SEM of cross section of asymmetric - membrane made with 5% water and 
CA/acetone weight ratios of: ( a ) 10/85, magnifi cation 5000 × ( b ) 15/80, magnifi cation 
12,000 × . 
(a)
(b)
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tion, in Figure  5 , concentration paths in time for the tablet coating prepared with 
5% CA, 90% acetone, and 5% water are shown. According to this plot, the phase 
separation takes place since the concentration paths in time for the drug tablet –
 coating and the coating – air interface cross the binodal curve at the same time. In 
addition, the coating – air interface enters the phase envelope at a polymer volume 
fraction of 0.76, while the tablet – coating interface enters with a volume fraction of 
0.023. These two observations imply that the coating will be porous and asymmetric 
in which the top layer is more dense than the lower sublayer, which was confi rmed 
by the SEM picture in Figure  2 . The predictions, have shown that phase separation 
was achieved for all coating formulations, supporting the morphological observa-
5
 FIGURE 4  SEM of the cross section of the asymmetric - membrane made with 10% water 
and CA – acetone weight ratios of ( a ) 10/80, magnifi cation 10,000 × , and ( b ) 15/75, magnifi ca-
tion 10,000 × . 
(a)
(b)
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 FIGURE 5  Ternary - phase diagram and concentration paths for coating made with 5% CA 
dissolved in 90% acetone and 5% water. 
 FIGURE 6  Concentration profi le of CA in membrane at moment of precipitation for dif-
ferent CA – acetone weight fraction ratios. 
tions and the precipitation times calculated for each case (listed in Table  1 ). Model 
predictions can also be used to determine a rough thickness of the high - polymer -
 concentration region near the coating – air interface and the pore distribution of the 
sublayer structure when the polymer concentration profi les at the moment of phase 
separation are plotted. As an illustration, such a plot is shown in Figure  6 for coat-
ings prepared with 10% CA in the casting solution. Examination of these profi les 
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leads to the following conclusions regarding the effect of increased water concentra-
tion: (1) The polymer concentration at the coating – air interface slightly decreases. 
(2) More uniform porosity distribution throughout the lower sublayer is favored. 
Also, porosity increases, which is in complete agreement with our release studies 
and the observations of other groups  [30, 33] . 
 Effect of Evaporation Condition  Previous studies on more traditional applica-
tions have investigated the effect of increased air velocity, that is, forced - convection 
conditions for a combination of dry/wet phase inversion techniques to produce 
defect - free, ultrahigh fl ux asymmetric membranes with ultrathin skin layers  [116 –
 118] . To investigate the effect of evaporation condition on the release rate of drug, 
tablets were dip coated with CA solution containing 10% CA, 80% acetone, and 
10% water and allowed to dry by blowing air across the surface with a blower 
(forced convection). As a comparison, tablets coated with the same solution were 
air dried under natural free - convection conditions. 
 As illustrated in Figure  7 , the release profi les of both tablet coatings show a linear 
behavior only at small times, and then exponential increases in concentrations were 
observed. Based on this behavior, the release profi les were fi tted to an empirical 
equation as
  C k t eb Ct= +⎣ ⎦0 1 0   (5) 
 where  k 0 and  b 0 are fi tting parameters. The accuracy of Equation  (5) for correlating 
the release rate data in Figure  7 was confi rmed by high  R 2 values, very close to 1 in 
both cases. Due to the presence of the second term in Equation  (5) , the release rate 
 FIGURE 7  Release of theophylline from tablet coatings made with 10% CA dissolved in 
80% acetone and 10% water. Coated tablets were dried under free - and forced - convection 
conditions. The lines correspond to prediction from Equation  (5) using  k 0  =  1.92  × 
 10  − 5  mg/(mL·min);  b 0  =  0.1179  mL/(mg·min) for forced convection and  k 0  =  2.41  × 
 10  − 5  mg/(mL·min);  b 0  =  0.1174  mL/(mg·min) for free convection. 
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of the drug,  dC/dt , is no longer constant and its dependency on the concentration 
of drug in the dissolution medium,  C , can be expressed as
  dC
dt
k e b Ct
k b t e
b Ct
b Ct
=
+ +⎣ ⎦
−
0 0
0 0
2
1 1
1
0
0
( )   
(6)
 
 Using Equation  (6) , the release rate of theophylline from the tablets dried under 
forced - and free - convection conditions were determined as 0.047 and 0.078  mg/min, 
respectively. It shoud be noted that both of these values correspond to the arithmetic 
average of the release rates calculated at each average concentration level shown 
in Figure  7 . The difference in release rates can be explained by comparing the scan-
ning electron micrographs shown in Figures  8 a and 8 b . It can be seen that the cross -
 sectional morphology of the tablet coating dried under the forced - convection 
condition is dense and nonporous while a porous and asymmetric structure is 
observed for the tablet coating dried under free - convection conditions. In the dense 
coating, diffusional resistance to transport of the drug occurs through the overall 
thickness and is larger than that in the asymmetric porous coating; hence, a lower 
drug release rate is observed. To understand the effect of air velocity on the forma-
tion of the coating structure, we have utilized our model predictions. The composi-
tion paths plotted in Figure  9 indicate that, when the speed of air in the drying 
atmosphere is signifi cantly increased, the rate of evaporation of solvent (acetone) 
increases dramatically and within a short time its concentration at the surface drops 
to zero. This situation leads to very strong diffusional resistance within the mem-
brane solution and, thus, slow evaporation of the nonsolvent (water). Consequently, 
phase separation is never achieved and the resulting membrane structure becomes 
dense as supported by the SEM picture in Figure  8 a . 
 Effect of Nonsolvent Type  A few studies in the literature have shown that various 
membrane morphologies can be obtained by changing the type of nonsolvent in 
the casting solution  [119 – 121] . To investigate the effect of nonsolvent type, tablet 
coatings were prepared from a casting solution of CA in acetone as a solvent and 
octanol, formamide, glycerol, and hexanol as nonsolvents. The drastic change in the 
release rates of theophylline and percentage of dense skin layer at the surface of 
the tablet coating with nonsolvent type is shown in Figure  10 . The decrease in the 
release rates is associated with the increase in the thickness of dense skin layer of 
the coating. The results illustrated in Figure  10 indicate that the membrane structure 
formation during the phase inversion process is strongly infl uenced by the type of 
nonsolvent, since each nonsolvent has different volatility, thermodynamic, and 
diffusion characteristics. The difference in the rates of evaporation and diffusion 
of nonsolvents and change in the miscibility gaps in the case of each nonsolvent 
lead to different mass transfer paths; consequently, the morphology of the resulting 
membrane structures signifi cantly varies from porous symmetric to dense asym-
metric ones. 
 Statistical Analysis of Experimental Design  The effect of the composition of the 
coating solution on the release rate of drug was investigated in detail with the 14 
formulations listed in Table  1 . The drug release rate was chosen as an appropriate 
c27.indd   1117 11/6/2007   7:30:31 PM
1118  CONTROLLED RELEASE OF DRUGS FROM TABLET COATINGS
response variable since zero - order release was easily achieved for all tablet coatings 
prepared. The data in Table  1 were best fi t by the special cubic equation
  Release rate = + + −
− −
70 94 1 698 37 55 94 66
354 3 49
1 2 3 1 2
1 3
. . . .
.
ω ω ω ω ω
ω ω . .3 357 662 3 1 1 3ω ω ω ω ω+
  
(7)
 
 Results of the regression analysis are given in Table  2 . An excellent fi t of the 
experimental release rate data to Equation  (7) was confi rmed by the high  R 2 value 
of 0.9801. In addition to the  R 2 values, the signifi cance of Equation  (7) and each 
 FIGURE 8  SEM of cross section of asymmetric - membrane made with 10% CA dissolved 
in 80% acetone and 10% water: ( a ) coating solution was dried under forced - convection 
condition, magnifi cation 6500 × ; ( b ) coating solution was dried under free - convection condi-
tion, magnifi cation 5000 × . 
(a)
(b)
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term in it to the prediction of the release rate of theophylline was evaluated by the 
 F statistic or  F value. The  F statistic is viewed as a ratio that expresses variance 
explained by the model divided by variance due to model error or experimental 
error and is defi ned as
  
F
R k
R n k
=
− − −
2
21 1
/
/( ) ( )
  
(8)
 
 FIGURE 9  Ternary - phase diagram and concentration paths for coating made with 10% CA 
dissolved in 80% acetone and 10% water. Coating solution was dried under forced - convec-
tion condition. 
 FIGURE 10  Release rates of theophylline and percentage of dense skin layer of mem-
branes as function of nonsolvent type. Polymer: CA solvent – acetone. 
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 where  k is the number of variables in the model. Usually the computed value of  F 
is compared with the critical  F value,  F k ,  n − k , 1 − α  , where  α is a preselected signifi cance 
level. If the value of  F is substantially greater than the critical  F value ( F critic ), that 
is, if  Δ F , the difference between  F and  F critic , is large, then the regression equation is 
considered useful in predicting the response. We have assessed the contribution of 
each interaction term by comparing the change in  Δ F and  R 2 values between the 
full model given in Equation  (7) and reduced models. The reduced models were 
obtained by deleting a specifi c interaction term in the full model; for example, model 
2 includes all terms in Equation  (7) except the term involving  ω 1 ω 2 ω 3 . The results 
in Table  2 indicate that all binary and ternary interaction terms in the full model 
are needed for accurate prediction of the release rate since the largest  Δ F values 
are calculated for the full model for both signifi cance levels,  α  =  0.05 and  α  =  0.01. 
According to the criterion mentioned above, among all interactions, CA – acetone 
( ω 1 ω 2 ) was identifi ed as the most infl uential factor on the response since the largest 
decrease in both  Δ F and  R 2 values compared to those of the full model were 
observed when the term  ω 1 ω 2 was deleted from the full model. This simply implies 
that changing the CA – acetone ratio in the coating formulation has the most signifi -
cant effect on the release rate. Specifi cally, increasing the ratio of CA to acetone 
from 5/90 to 15/80 resulted in a decrease of the release rate from 0.45 to 0.036  mg/
min since the porosity of the membrane decreases and the thickness of the dense 
skin layer increases. The ratio of the composition of CA to water ( ω 1 ω 3 ) was also 
found to be an important parameter on the release rate of drug as indicated by the 
second largest decrease in  R 2 and  Δ F values compared to those of the full model. 
Decreasing this ratio from 15/5 to 5/15 caused an increase in the release rate by a 
factor of 10 since the thickness of the dense skin layer signifi cantly decreases. Based 
on the decrease in  Δ F and  R 2 values from those of the full model given in Table  2 , 
the relative importance of each interaction term can be ranked as follows:  ω 1 ω 2  > 
 ω 1 ω 3  >  ω 2 ω 3  >  ω 1 ω 2 ω 3 . 
 To further illustrate the simultaneous effects of the factors on the release rate of 
drug, a three - dimensional response surface plot based on Equation  (7) was gener-
ated, as shown in Figure  11 . As can be clearly seen from this fi gure, the release rate 
can be signifi cantly varied just by tailoring the CA – acetone and CA – water ratios 
without changing the coating material. In addition, Figure  11 shows that a slight 
maximum in release rate is observed as the ratio of composition of acetone to water 
increases. 
 In order to validate the predictive capability of the empirical expression, two 
formulations with compositions given in Table  3 were selected randomly from the 
 TABLE 2  Statistical Analysis of Release Rate Data 
 Model Number  R 2  F values 
 α  =  0.05  α  =  0.01 
 F critic  a   Δ F  F critic a  Δ F 
 1 (full model)  0.9801  42.21  4.21  38  8.26  33.95 
 2 ( ω 1 ω 2 ω 3 )  0.955  25.13  3.87  21.26  7.19  17.94 
 3 ( ω 2 ω 3 )  0.953  23.57  3.87  19.7  7.19  16.38 
 4 ( ω 1 ω 3 )  0.946  20.64  3.87  16.77  7.19  13.45 
 5 ( ω 1 ω 2 )  0.881  8.65  3.87  4.78  7.19  1.46 
  a  Determined from statistical tables  [122] . 
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 FIGURE 11  Three - dimensional response surface plot of release rate as function of com-
position of coating solution. 
0.40
0.30
0.20
0.09
–0.01
ω1 (0.25)
ω2 (0.70)
ω2 (0.90)
ω3 (0.25)
ω1 (0.05)
ω3 (0.25)
Weight fraction
R
el
ea
se
 r
at
e 
(m
g/
m
in
)
experimental design region. Experimental release rates estimated from the slope of 
the release profi les and corresponding rates predicted from Equation  (7) are also 
listed in Table  3 . According to the results, the maximum absolute percentage differ-
ence between the experimental and predicted release rates is 3.5%. This value lies 
within the residuals obtained in deriving Equation  (7) . Based on this comparison, 
it is fair to conclude that the empirical expression derived in this study can be used 
as a tool to predict the release rate of theophylline for any composition within the 
experimental design region. 
 6.5.7  CONCLUSION 
 This chapter has considered the controlled release of drugs from tablet coating 
systems. These systems are still the preferred route of drug administration due to 
 TABLE 3  Composition of Coating Solution Randomly Selected for Testing Predictive 
Capability of Empirical Expression 
 Compositon (wt %) 
 Experimental 
Release Rate 
(mg/min) 
 Predicted 
Release Rate 
(mg/min)  R 2 
 Cellulose 
Acetate  Acetone  Water 
 7.5  82.5  10  0.09  0.125  0.9816 
 10  82.5  7.5  0.027  0.029  0.9858 
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their advantages of ease of administration, maintaining zero - order release rates, and 
better patient compliance; thus, they hold the major market share in the pharma-
ceutical industry along with the other formulations of oral drug delivery. In tablet 
coated systems, diffusion of drug through the coating is usually the rate - limiting step 
and the desired drug release rates are achieved by properly selecting the coating 
material and adjusting the morphology of the coating using suitable manufacturing 
methods. Coating characteristics such as glass transition temperature, crystalline 
content, and degree of cross - linking signifi cantly determine the release rate of the 
drug. For a selected coating material, the structure of the coating plays a critical role 
in achieving useful release rates. The morpholology of the tablet coatings can be 
varied by incorporating plasticizer or water - soluble additives in the coating solution, 
by blending the polymers, or by applying multilayer composite coatings. Another 
approach is to apply asymmetric - and porous - type coatings. The morphological 
characteristics of these types of coatings, such as fraction of dense top layer and 
porous sublayer and size and shape of the pores, can be varied by optimizing the 
composition of the coating solution, evaporation conditions (temperature, relative 
humidity, and velocity of air), and the type of solvent or nonsolvent used in the 
coating solution. Asymmetric - type coatings can be used to facilitate osmotic deliv-
ery of drugs with low solubilities since high water fl uxes can be achieved. These 
coatings allow us to control the release kinetics without altering the coating material 
or signifi cantly varying the coating thickness. 
 Currently, considerable research efforts have been directed toward developing 
protein drug delivery systems due to discovery of numerous protein and peptide 
therapeutics. The delivery of protein drugs is usually limited to parenteral adminis-
tration and frequent injections are required due to their short half - lives in the blood. 
In this regard, development of oral delivery systems is necessary for patient compli-
ance and convenience. The challenge in the design of the oral delivery systems is 
that they should protect the incorporated drugs from chemical and enzymatic deg-
radation until the drug reaches the delivery site. The protein drug should not be 
infl uenced by pH or bacteria and enzymes along the gastrointestinal (GI) tract and 
should be delivered at the desired site with a desired effi ciency. To achieve site -
 specifi c delivery for protein - and peptide - based drugs, one of the strategies that has 
often been investigated is to coat the drug core with polymers that can respond to 
the stimuli of local environments such as pH and enzymes. For water - soluble protein 
drugs, such as insulin, an additional protective coating is usually required to isolate 
the drug from the surrounding water. Composite tablet coating materials which 
combine the enzymatic susceptibility and protective properties of polymers can be 
another solution for this problem. A systematic comparison study among various 
polymer combinations is required to select the appropriate coating materials for 
specifi c drugs. Not only the selection of the coating material but also the manufac-
turing technique for the preparation of tablet coatings plays a critical role and still 
remains one of the most challenging subjects in the controlled drug delivery area. 
Proteins are very sensitive to conditions that can occur during the coating process. 
Mechanical stresses during the preparation, exposure to a hydrophobic organic 
solvent, intermediate moisture level during hydration, and interaction between 
protein and polymer can easily inactivate the protein - based drug. Therefore, more 
research focused on both optimization of coating materials and manufacturing 
methods for encapsulating the protein and peptide drugs is necessary. 
6
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 FIGURE A2  Release of theohylline from tablet coatings made with 10% CA dissolved in 
85% acetone and 5% water. 
 FIGURE A1  Release of theohylline from tablet coatings made with 5% CA dissolved in 
90% acetone and 5% water. 
 APPENDIX 
 The in vitro release profi les of the model drug theophylline are shown below in 
Figures  A1 through A10 . 
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 FIGURE A4  Release of theohylline from tablet coatings made with 5% CA dissolved in 
85% acetone and 10% water. 
 FIGURE A3  Release of theohylline from tablet coatings made with 15% CA dissolved in 
80% acetone and 5% water. 
APPENDIX  1131
c27.indd   1131 11/6/2007   7:30:34 PM
1132  CONTROLLED RELEASE OF DRUGS FROM TABLET COATINGS
 FIGURE A6  Release of theohylline from tablet coatings made with 15% CA dissolved in 
75% acetone and 10% water. 
 FIGURE A5  Release of theohylline from tablet coatings made with 10% CA dissolved in 
80% acetone and 10% water. 
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 FIGURE A8  Release of theohylline from tablet coatings made with 10% CA dissolved in 
75% acetone and 15% water. 
 FIGURE A7  Release of theohylline from tablet coatings made with 5% CA dissolved in 
80% acetone and 15% water. 
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1134  CONTROLLED RELEASE OF DRUGS FROM TABLET COATINGS
 FIGURE A10  Release of theohylline from tablet coatings made with 12.5% CA dissolved 
in 77.5% acetone and 10% water. 
 FIGURE A9  Release of theohylline from tablet coatings made with 15% CA dissolved in 
70% acetone and 15% water. 
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During the preparation of your manuscript for publication, the questions listed 
below have arisen. Please attend to these matters and return this form with your 
proof.
Many thanks for your assitstance. 
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